Eur Respir J. 2020 Aug 13;56(2):2002108. doi: 10.1183/13993003.02108-2020. Print 2020 Aug.
ABSTRACT
COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. This may be related to poor underlying lung reserves or increased expression of ACE-2 receptor in small airways.
PMID:32817205 | PMC:PMC7424116 | DOI:10.1183/13993003.02108-2020